Characterization and messenger ribonucleic acid distribution of a cloned pituitary adenylate cyclase-activating polypeptide type I receptor in the frog Xenopus laevis brain

Endocrinology

Volumn 141, Issue 2, 2000, Pages 657-665

  Hu, Z ^a   Lelievre, V ^a   Chao, A ^a   Zhou, X ^a   Waschek, J A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR 1; MESSENGER RNA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; CEREBELLUM NUCLEUS; DNA LIBRARY; IN SITU HYBRIDIZATION; MOLECULAR CLONING; NEUROHYPOPHYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OOCYTE; PREOPTIC NUCLEUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PURKINJE CELL; RNA HYBRIDIZATION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; XENOPUS LAEVIS;

EID: 0034465671     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.2.7316     Document Type: Article

References (34)

1. International union of pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide
2. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP/VIP receptors: Actions on the anterior pituitary gland
3. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal peptide
4. Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells
5. Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type 1 receptor
6. Pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors: Neuroendocrine and endocrine interaction
7. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions
8. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells
9. Molecular cloning and functional expression of a cDNA encoding a human pituitary adenylate cyclase activating polypeptide receptor
10. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates cyclic AMP formation as well as peptide output of cultured pituitary, melanotrophs and At T-20 corticotrophs
11. Differential effects of peptide histidine isoleucine (PHI) and related peptides on stimulation and suppression of neuroblastoma cell proliferation. A novel VIP-independent action of PHI via MAP kinase
12. Auto-radiographic visualization of the receptor subclasses for vasoactive intestinal polypeptide (VIP) in rat brain
13. Cloning and functional characterization of the human vasoactive intestinal peptide (VIP)-2 receptor
14. Distribution of the mRNA for a pituitary adenylate cyclase-activating polypeptide receptor in the rat brain: An in situ hybridization study
15. Pituitary adenylate cyclase activating polypeptide (PACAP): Discovery and current status of research
16. Neuroanatomical and physiological evidence for the involvement of pituitary adenylate cyclase-activating polypeptide in the regulation of the distal lobe of the frog pituitary
17. Pituitary adenylate cyclase-activating polypeptide stimulates calcium mobilization in amphibian pituitary cells
18. Pituitary adenylate cyclase-activating polypeptide stimulates both adrenocortical cells and chromaffin cells in the frog adrenal gland
19. Immunohistochemical distribution and biological activity of pituitary adenylate cyclase-activating polypeptide (PACAP) in the central nervous system of the frog Rana ridibunda
20. Neural tube expression of pituitary adenylate cyclase-activating peptide (PACAP) and receptor: Potential role in patterning and neurogenesis
21. 2 receptors in mammals
22. Alternative splicing in the N-terminal extracellular domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor modulates receptor selectivity and relative potencies of PACAP-27 and PACAP-38 in phospholipase C activation
23. A family of receptors coupled to guanine nucleotide regulatory proteins
24. Hypophysioltropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: Immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor
25. The VIP2 receptor: Molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal peptide
26. The amino-terminal fragment of the adenylate cyclase activating polypeptide (PACAP) receptor functions as a high affinity PACAP binding domain
27. Differential signal-transduction by five splice variants of the PACAP receptor
28. Mutational analysis of cysteine residues within the extracellular domains of the human vasoactive intestinal peptide (VIP) 1 receptor identifies seven mutants that are defective in VIP binding
29. A disulfide bond between conserved cysteines in the extracellular loops of the human VIP receptor is required for binding and activation
30. Mutagenesis of N-glycosylation sites in the human vasoactive intestinal peptide I receptor. Evidence that asparagine 58:69 is crucial for correct delivery of the receptor to plasma membrane
31. Expression of pituitary adenylate cyclase activating peptide (PACAP) and PACAP type I receptors in the rat adrenal medulla
32. Localization and gene expression of the receptor for pituitary adenylate cyclase-activating polypeptide in the rat brain
33. Characterization and localization of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites in the brain of the frog Rana ridibunda